- Investing Ideas
- Global Pharmaceuticals & Biotech Top Growth Stocks
Global Pharmaceuticals & Biotech Top Growth Stocks
Results
70
70 companies
Axsome Therapeutics
Market Cap: US$11.1b
A biopharmaceutical company, develops and delivers novel therapies for the management of central nervous system (CNS) disorders in the United States.
AXSM
US$211.97
7D
0.4%
1Y
78.7%
Pharma Mar
Market Cap: €1.3b
A biopharmaceutical company, focuses on the research, development, production, and commercialization of bio-active principles for the use in oncology in Spain, Germany, Ireland, France, Switzerland, rest of the European Union, the United States, and internationally.
PHM
€76.25
7D
-3.1%
1Y
-16.4%
Madrigal Pharmaceuticals
Market Cap: US$12.1b
A biopharmaceutical company, focuses on delivering novel therapeutics for metabolic dysfunction-associated steatohepatitis (MASH) in the United States.
MDGL
US$529.09
7D
-3.2%
1Y
26.7%
TG Therapeutics
Market Cap: US$7.5b
A commercial stage biopharmaceutical company, focuses on the acquisition, development, and commercialization of novel treatments for B-cell mediated diseases in the United States and internationally.
TGTX
US$55.85
7D
2.2%
1Y
74.3%
L&C BIOLTD
Market Cap: ₩1.2t
Operates as a research and development company in tissue regeneration medicine.
A290650
₩46,500.00
7D
-5.5%
1Y
-24.0%
Sichuan Kelun-Biotech Biopharmaceutical
Market Cap: HK$110.1b
A biopharmaceutical company, engages in the research and development, manufacturing, and commercialization of novel drugs in oncology, immunology, metabolism, and other therapeutic areas in the People’s Republic of China and internationally.
6990
HK$461.40
7D
-2.7%
1Y
-9.5%
Camurus
Market Cap: SEK 34.3b
A biopharmaceutical company, develops and commercializes medicines for severe and chronic diseases in Europe, Africa, the Middle East, North America, and Asia.
CAMX
SEK 577.00
7D
-2.0%
1Y
-16.4%
Oscotec
Market Cap: ₩1.3t
Operates as a biotechnology company, engages in the drug development, functional materials and related products, and dental bone graft material businesses.
A039200
₩37,450.00
7D
5.6%
1Y
-9.7%
Kuros Biosciences
Market Cap: CHF 672.9m
Engages in the commercialization and development of biologic technologies for musculoskeletal care in the United States of America, the European Union, and internationally.
KURN
CHF 16.96
7D
-9.9%
1Y
-28.2%
MedinCell
Market Cap: €775.7m
Engages in the research and development of biodegradable polymer-based processes for the controlled and prolonged delivery of active pharmaceutical ingredients into the human body and animals in France.
MEDCL
€21.60
7D
-1.9%
1Y
4.7%
Insmed
Market Cap: US$26.2b
Develops and commercializes therapies for patients with serious and rare diseases in the United States, Europe, Japan, and internationally.
INSM
US$122.58
7D
-4.8%
1Y
-15.3%
Neuren Pharmaceuticals
Market Cap: AU$2.6b
A biopharmaceutical company, develops drugs for the treatment of neurological disorders.
NEU
AU$20.54
7D
1.6%
1Y
2.0%
HansBiomed
Market Cap: ₩265.5b
Engages in the research and development, production, and sale of medical materials for the procedure and the raw materials for medical supplies.
A042520
₩18,160.00
7D
-9.7%
1Y
13.5%
Praxis Precision Medicines
Market Cap: US$8.7b
A clinical-stage biopharmaceutical company, engages in the development of therapies for central nervous system (CNS) disorders characterized by neuronal excitation-inhibition imbalance in the United States.
PRAX
US$308.99
7D
-10.5%
1Y
601.8%
Ardelyx
Market Cap: US$844.7m
Ardelyx, Inc. discovers, develops, and commercializes medicines to treat unmet medical needs in the United States and internationally.
ARDX
US$3.39
7D
-6.4%
1Y
-47.2%
Rhythm Pharmaceuticals
Market Cap: US$6.7b
A commercial-stage biopharmaceutical company, focuses on the rare neuroendocrine diseases in the United States and internationally.
RYTM
US$98.01
7D
-3.0%
1Y
2.0%
Botanix Pharmaceuticals
Market Cap: AU$49.3m
A pharmaceutical company, engages in the research and commercialization of solutions for skin diseases and infections in Australia and the United States.
BOT
AU$0.018
7D
-5.3%
1Y
-85.6%
Akeso
Market Cap: HK$83.3b
A biopharmaceutical company, engages in the research, development, manufacture, and commercialization of antibody drugs worldwide.
9926
HK$90.75
7D
-3.0%
1Y
-30.7%
Ionis Pharmaceuticals
Market Cap: US$7.9b
A commercial-stage biotechnology company, provides RNA-targeted medicines in the United States.
IONS
US$44.84
7D
-20.0%
1Y
-26.7%
WuXi XDC Cayman
Market Cap: HK$94.8b
An investment holding company, operates as a contract research, development, and manufacturing organization in China, North America, Europe, and internationally.
2268
HK$76.50
7D
4.7%
1Y
7.4%
Cellectar Biosciences
Market Cap: US$22.3m
A clinical biopharmaceutical company, focuses on the discovery, development, and commercialization of drugs for the treatment of cancer in the United States.
CLRB
US$2.35
7D
-0.8%
1Y
-57.2%
Aldeyra Therapeutics
Market Cap: US$82.6m
A biotechnology company, discovers and develops therapies designed to treat immune-mediated diseases.
ALDX
US$1.37
7D
-6.2%
1Y
-72.7%
DBV Technologies
Market Cap: €620.2m
A clinical-stage biopharmaceutical company, engages in the research and development of epicutaneous immunotherapy products in France.
DBV
€2.10
7D
-11.1%
1Y
30.3%
Revolution Medicines
Market Cap: US$43.9b
A clinical-stage precision oncology company, develops novel targeted therapies for RAS-addicted cancers.
RVMD
US$195.92
7D
-5.7%
1Y
347.2%
Corcept Therapeutics
Market Cap: US$12.0b
A biopharmaceutical company, engages in the discovery and development of medications to treat severe endocrinologic, oncologic, metabolic, and neurologic disorders in the United States.
CORT
US$111.81
7D
-3.4%
1Y
48.7%
Capricor Therapeutics
Market Cap: US$497.7m
A clinical-stage biotechnology company, engages in the development of transformative cell and exosome-based therapeutics for treating duchenne muscular dystrophy (DMD) and other diseases with unmet medical needs in the United States.
CAPR
US$8.56
7D
-0.9%
1Y
40.8%
Kiniksa Pharmaceuticals International
Market Cap: US$5.9b
A biopharmaceutical company, develops and commercializes medical therapies in the United States, the United Kingdom, and internationally.
KNSA
US$77.62
7D
-1.1%
1Y
119.1%
MindMaze Therapeutics Holding
Market Cap: CHF 26.2m
Operates as a commercial-stage biopharmaceutical and neurotechnology company in Asia, the United States, Switzerland, rest of Europe, and internationally.
MMTX
CHF 0.15
7D
-11.5%
1Y
n/a
Arcutis Biotherapeutics
Market Cap: US$3.0b
A biopharmaceutical company, focuses on developing and commercializing treatments for dermatological diseases.
ARQT
US$26.14
7D
9.6%
1Y
52.5%
Eton Pharmaceuticals
Market Cap: US$1.6b
A pharmaceutical company, focuses on developing and commercializing treatments for rare diseases.
ETON
US$56.35
7D
-2.6%
1Y
205.3%
Grace Therapeutics
Market Cap: US$46.9m
Engages in the development and commercialization of pharmaceutical products for rare and orphan diseases in Canada.
GRCE
US$2.14
7D
0%
1Y
-30.1%
Oxford Biomedica
Market Cap: UK£544.1m
A contract development and manufacturing organization, focuses on delivering therapies to patients worldwide.
OXB
UK£4.50
7D
1.2%
1Y
-23.6%
CG Oncology
Market Cap: US$6.6b
A late-stage clinical biopharmaceutical company, develops and commercializes cretostimogene grenadenorepvec for patients with bladder cancer in the United States.
CGON
US$74.12
7D
2.9%
1Y
90.9%
Nuvation Bio
Market Cap: US$2.0b
A clinical-stage biopharmaceutical company, focuses on developing product candidates for cancer treatment.
NUVB
US$5.78
7D
-11.3%
1Y
77.3%
AC Immune
Market Cap: US$264.5m
A clinical stage biopharmaceutical company, discovers, designs, and develops medicines, and therapeutic and diagnostic products for the prevention and treatment of neurodegenerative diseases associated with protein misfolding.
ACIU
US$2.65
7D
-1.5%
1Y
5.2%
PharmaResearch
Market Cap: ₩3.4t
Operates as a biopharmaceutical company primarily in South Korea.
A214450
₩329,500.00
7D
-5.7%
1Y
-45.8%